1. Li, Ke, Guo, Jiawei, Ming, Yue, Liu, Wenrong, Peng, Yong. 2023. A circular RNA activated by TGFβ promotes tumor metastasis through enhancing IGF2BP3-mediated PDPN mRNA stability. In Nature communications, 14, 6876. doi:10.1038/s41467-023-42571-1. https://pubmed.ncbi.nlm.nih.gov/37898647/
2. Jordan, Valerie K, Zaveri, Hitisha P, Scott, Daryl A. 2015. 1p36 deletion syndrome: an update. In The application of clinical genetics, 8, 189-200. doi:10.2147/TACG.S65698. https://pubmed.ncbi.nlm.nih.gov/26345236/
3. Feng, Chunyan, Yu, Albert, Wang, Zhongfu, Dai, Xiaoyong, Huang, Laiqiang. 2024. A novel PDPN antagonist peptide CY12-RP2 inhibits melanoma growth via Wnt/β-catenin and modulates the immune cells. In Journal of experimental & clinical cancer research : CR, 43, 9. doi:10.1186/s13046-023-02910-y. https://pubmed.ncbi.nlm.nih.gov/38167452/
4. Wang, Xuya, Wang, Xisen, Li, Jiabo, Yu, Shengping, Yang, Xuejun. 2022. PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma. In Cancer gene therapy, 30, 345-357. doi:10.1038/s41417-022-00550-6. https://pubmed.ncbi.nlm.nih.gov/36434176/
5. Gagliano Taliun, Sarah A, Sulem, Patrick, Sveinbjornsson, Gardar, Paterson, Andrew D, Barua, Moumita. 2022. GWAS of Hematuria. In Clinical journal of the American Society of Nephrology : CJASN, 17, 672-683. doi:10.2215/CJN.13711021. https://pubmed.ncbi.nlm.nih.gov/35474271/